We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Results for
"[search-keyword]"
Sponsor content
19 result(s) found, displaying 1 to 10
-
May-2024Prescription medicine evaluationActive ingredient: lonapegsomatropin.
-
Apr-2024Prescription medicine evaluationActive ingredient: palopegteriparatide.
-
Designation or determinationOrphan drug
-
Designation or determinationPriority review
-
Cancellation by sponsorRequested by Specialised Therapeutics Pharma Pty Ltd
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZEPZELCA lurbinectedin 4 mg powder for solution for infusion 1 vial per carton.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YONDELIS trabectedin 1 mg powder for solution for infusion vial.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Lurbinectedin
-